Introduction
============

Knee osteoarthritis (KOA) is a chronic degenerative joint inflammation that cannot be cured. It is also the most common adult joint disease in the world, which is more common in the middle-aged and the elderly ([@b1-etm-0-0-8825]). According to the statistics, the prevalence of KOA in men aged over 65 years is \~13%, while that in women is \~24% ([@b2-etm-0-0-8825]). There are many studies on the treatment of KOA. However, so far, there is no way to cure this disease, most of the patients were operated with joint replacement surgery to relieve pain ([@b3-etm-0-0-8825]). Once KOA gets into the terminal stage, the function of knee joint in moving will be seriously damaged, resulting in physical imbalance, pain and dysfunction, as well as depression, which will indirectly aggravate the disease, and have a negative impact on the quality of life of middle-aged and elderly patients with KOA ([@b4-etm-0-0-8825]). In addition, the lack of specific clinical manifestations make the disease hard to establish in the early diagnosis of KOA ([@b7-etm-0-0-8825]). Therefore, it is of great significance to explore the biomarkers of the course of KOA for early diagnosis and prognosis evaluation.

Toll-like receptor (TLR) is a type I transmembrane protein, which plays a guiding role in the recognition of invasive pathogenic microorganisms in immune response ([@b8-etm-0-0-8825],[@b9-etm-0-0-8825]). Interferon regulatory factor (IRF) is a necessary regulator of differentiation and maturation of T cells, B cells and plasma cells ([@b10-etm-0-0-8825]), and is also a group of transcription factors that can regulate interferon and its signaling pathway ([@b11-etm-0-0-8825]). Both play an important role in virus defense, immune regulation, cell growth and apoptosis, and regulation of many inflammatory diseases ([@b12-etm-0-0-8825]). According to literature, TLR may drive many chronic inflammatory molecules in arthritis, including KOA, and Toll-like receptor-4 (TLR-4), Toll-like receptor-5 (TLR-5) are TLR expressed in plasma membrane. Once activated, they can activate downstream signal transduction pathways with cohesion molecules to activate IRF, a pro-inflammatory and joint destruction medium ([@b13-etm-0-0-8825],[@b14-etm-0-0-8825]). In the study of Nair *et al* ([@b15-etm-0-0-8825]), the expression of TLR-4 in synovial cells of patients with early KOA was significantly higher than that of healthy people. There was a certain correlation between TLR-4 and KOA, suggesting that TLR-4 may be a potential therapeutic target for KOA. In the report by Chamberlain *et al* ([@b16-etm-0-0-8825]), there was a positive correlation between TLR-5 and the severity of KOA, suggesting that TLR-5 can be used as a new marker for the diagnosis of knee arthritis. Yang *et al* ([@b17-etm-0-0-8825]), reported interferon regulatory factor 4 (IRF4), as a nonspecific transcription factor of Th17 cells, involved in the regulation of Th17 cell differentiation. By interfering with the expression of IRF4 and Th17 cell differentiation and IL-17 production can be significantly reduced, thus reducing disease inflammation ([@b18-etm-0-0-8825]). However, there is little research on the role of TLR-4, TLR-5 and IRF4 in KOA. A previous study on KOA pro-inflammatory cytokines showed that a large number of matrix metalloproteinases, including matrix metalloproteinase-1 (MMP-1), can be produced in KOA chondrocytes and synoviocytes, and the pro-inflammatory cytokine interleukin-1β (IL-1β), interleukin-6 (IL-6), and tumor necrosis factor-α (TNF-α) can also be secreted in synoviocytes, suggesting MMP-1, IL-1β, IL-6, TNF-α may be involved in the occurrence and progression of KOA ([@b19-etm-0-0-8825]). It has been reported that cytokines involved in the regulation of KOA inflammation also affect the pathogenesis of KOA through angiogenesis and chemotaxis. Studies on cytokine gene polymorphisms contribute to the determination of susceptibility to KOA in populations and KOA, and identification of KOA and rheumatoid arthritis ([@b20-etm-0-0-8825],[@b21-etm-0-0-8825]). The induction of KOA is mainly related to the metabolic imbalance of cartilage cells and the high expression of pro-inflammatory cytokines. The treatment and diagnosis can start with restoring the metabolic level of cartilage cells and improving inflammatory response ([@b22-etm-0-0-8825]). Therefore, chondrocyte metabolic balance and inflammatory response markers play an important role in the occurrence and progression of KOA.

In this study, the expression of TLR-4, TLR-5 and IRF4 in serum of patients with KOA were detected, and the value of combined detection of serum TLR-4, TLR-5 and IRF4 in the diagnosis and prognosis of KOA was evaluated, and the correlation between TLR-4, TLR-5 and IRF4 and cartilage metabolism and inflammatory response markers was analyzed.

Materials and methods
=====================

### General information

Patients with KOA admitted to Puyang Hospital of Traditional Chinese Medicine (Puyang, China) from May 2016 to June 2018 were selected as subjects. In the study group, 68 patients with KOA were included, including 19 males and 49 females. They were aged 41-80 years, with a mean age of 54.38±13.89 years. There were 10 patients with suspected mild KOA, 18 patients with mild KOA, 20 patients with moderate KOA, and 20 patients with severe KOA. The control group included 49 healthy people with physical examination in Puyang Hospital of Traditional Chinese Medicine at the same time, including 15 males and 34 females. The controls were aged 40-80 years, with a mean age of 55.15±15.69 years. The guardians of the subjects were given full information regarding the study and signed and informed consent form. The study was approved by the Ethics Committee of Puyang Hospital of Traditional Chinese Medicine.

### Inclusion and exclusion criteria

Inclusion criteria: The patients in the study group met the diagnostic criteria of osteoarthritis of the American Society of Rheumatology ([@b23-etm-0-0-8825]), they were aged 40 to 80 years, and all of them were treated for the first time. The inclusion criteria were applied to the study group. Exclusion criteria: Patients with communication disorders, with incomplete clinical information, with complications of heart, liver, kidney and other important organs, with long-term use of non-steroidal anti-inflammatory drugs, cartilage protective drugs, painkillers, with contra-indications for the drugs used in this study, with history of knee trauma surgery, knee joint infection, knee deformity, metabolic osteopathy, unequal length of lower extremities, history of knee tumor, were excluded.

### Test methods

Venous blood (5 ml) of the two groups was drawn on an empty stomach in the morning, and the blood was placed in constant 37˚C temperature in a water bath. After 30 min, the blood was taken out and placed in the centrifuge tube for centrifugation at 1,500 x g and 4˚C for 10 min; the supernatant was taken out, and then stored in the refrigerator at -70˚C. The serum was removed from the freezer, dissolved in a refrigerator at 4˚C, and completely dissolved at room temperature. The concentrations of TLR-4, TLR-5, IRF4, IL-1β and IL-6, MMP-1, TNF-α in serum of two groups of patients were detected by enzyme linked immunosorbent assay (ELISA) ([@b24-etm-0-0-8825]). The ELISA kit was purchased from Xinfan Biotechnology Co., Ltd. Sample well to be tested, standard well and blank well were set up. No enzyme-labeled reagent and sample were added to the blank well, and 100 µl samples or standard substances were added to the remaining wells. After mixing, the enzyme-labeled plate was covered with film and incubated at 37˚C for 2 h. Each well was emptied, shaken, and dried, 100 µl of working fluid A was added to each well, covered with film, and incubated at 37˚C for 1 h. Each well was emptied, shaken, and dried, and washing liquid was added to wash the plate 3 times. Each well was added with 100 µl of working liquid B, covered with film, and incubated at 37˚C for 1 h. Each well was emptied, shaken, and dried, and washing liquid was added to wash the plate 3 times. Each well was added with 90 µl of substrate solution, covered with film, and placed at 37˚C to develop color for 10-15 min. Solution (50 µl) was added to each well to end the reaction. SAF-680T enzyme labeling instrument (Shanghai Bajiu Industrial Co., Ltd.) was used to detect the OD value of each well at 450 nm wavelength.

### Statistical analysis

The count data were expressed by \[n (%)\] and were compared using the χ^2^ test. The measurement data were expressed by \[mean ± standard deviation (SD)\] and were analyzed using t-test. GraphPad Prism 7 was used to draw graphs of the expression level. The comparison between the two groups was made by independent sample t-test, and one-way ANOVA followed by Bonferroni test used for comparison of multiple groups. Correlation graphs were drawn with GraphPad Prism 7. Correlation between cytokine and grading was analyzed using Spearman correlation coefficient. Correlation between serum TLR-4, TLR-5, IRF4 and cytokines was analyzed using Pearson\'s correlation coefficient. The receiver operating characteristic (ROC) curve was used to analyze the single diagnostic efficacy. On the base of the analysis of single diagnostic efficacy, SPSS 20.0 (IBM Corp.) was used for the bivariate regression analysis of the combined diagnostic efficacy. P\<0.05 was considered to indicate a statistically significant difference.

Results
=======

### Comparison of general information between two groups of people

There was no significant difference in sex, age, body mass index (BMI), smoking history, place of residence, educational level, eating habits, alcohol abuse or marital status between the two groups (P\>0.05) ([Table I](#tI-etm-0-0-8825){ref-type="table"}).

### Expression of serum TLR-4, TLR-5 and IRF4 of study group and control group

Expression of serum TLR-4 in the study group and the control group were, respectively, 9.52±5.45 and 2.58±1.76 ng/l. Expression of serum TLR-5 in the study group and the control group were, respectively, 9.23±6.24 and 2.01±1.55 ng/l. Expression of serum IRF4 in the study group and the control group were, respectively, 15.22±7.75 and 5.89±1.26 ng/l, respectively. Expression of serum TLR-4, TLR-5 and IRF4 in the study group was significantly higher than those in the control group (P\<0.001) ([Fig. 1](#f1-etm-0-0-8825){ref-type="fig"}).

### Serum TLR-4, TLR-5 and IRF4 levels in patients with different K-L grades

The K-L (Kellgren-Lawrence) ([@b25-etm-0-0-8825]) scoring system is the most widely used system for KOA, using X-ray photographs to determine the severity of the condition. Grade 0 represents normal knee joint; Grade I represents suspected mild KOA; Grade II represents mild KOA; Grade III represents moderate KOA, and grade IV represents severe KOA. Among our patients, there were 10 in grade I, 18 in grade II, 20 in grade III and 20 in grade IV. Compared with grade I of K-L, the levels of serum TLR-4, TLR-5 and IRF4 in patients of grade II, III and IV in the study group were significantly higher (P\<0.05). Compared with grade II of K-L, the levels of serum TLR-4, TLR-5 and IRF4 in patients of grade III and IV in the study group were significantly higher (P\<0.05). Compared with grade III of K-L, serum TLR-4, TLR-5 and IRF-4 levels were significantly higher in patients of grade IV in the study group (P\<0.05). The levels of serum TLR-4, TLR-5 and IRF4 in the study group increased with the increase of K-L grade ([Fig. 2](#f2-etm-0-0-8825){ref-type="fig"}).

### Correlation between serum TLR-4, TLR-5 and IRF4 levels and different K-L grades

According to the K-L grades, the K-L grades are grade I to 1, grade II to 2, grade III to 3 and grade IV to 4. The results of Spearman correlation coefficient showed that there was a positive correlation between serum TLR-4, TLR-5, IRF4 and K-L grade (r=0.734, P\<0.001, r=0.701, P\<0.001, r=0.784, P\<0.001) ([Fig. 3](#f3-etm-0-0-8825){ref-type="fig"}).

### Diagnostic efficacy of serum TLR-4, TLR-5 and IRF4 levels in KOA

ROC curve of serum TLR-4, TLR-5 and IRF4 levels was drawn for the diagnosis of KOA. The AUC of serum TLR-4 in the diagnosis of KOA was 0.865 (95% CI, 0.796-0.934), the cut-off value was 5.38 ng/l; the diagnostic sensitivity was 76.47%, and the specificity was 93.88%. The AUC of serum TLR-5 in the diagnosis of KOA was 0.843 (95% CI, 0.801-0.929), the cut-off value was 4.05 ng/l; the diagnostic sensitivity was 73.29%, and the specificity was 87.76%. The AUC of serum IRF4 in the diagnosis of KOA was 0.861 (95% CI, 0.792-0.930), the cut-off value was 7.68 ng/l; the diagnostic sensitivity was 72.06%, and the specificity was 95.92%. The AUC of KOA diagnosed by TLR-4, TLR-5 and IRF4 was 0.971 (95% CI, 0.959-1.004), the cut-off value was 0.63; the diagnostic sensitivity was 94.12%, and the specificity was 97.96 ([Table II](#tII-etm-0-0-8825){ref-type="table"} and [Fig. 4](#f4-etm-0-0-8825){ref-type="fig"}).

### Comparison of serum IL-1β, IL-6, MMP-1 and TNF-α levels between control group and study group (mean ± SD)

The levels of serum IL-1β, IL-6, MMP-1 and TNF-α in the study group were significantly higher than those in the control group (P\<0.001). Pearson\'s correlation analysis showed that the concentrations of serum TLR-4, TLR-5 and IRF4 were positively correlated with the concentrations of serum IL-1β, IL-6, MMP-1 and TNF-α, respectively (r=0.748, P\<0.001, r=0.720, P\<0.001, r=0.735, P\<0.001, r=0.742, P\<0.001, r=0.807, P\<0.001, r=0.799, P\<0.001, r=0.811, P\<0.001, r=0.822, P\<0.001, r=0.758, P\<0.001, r=0.752, P\<0.001, r=0.779, P\<0.001, r=0.765, P\<0.001) ([Figs. 5](#f5-etm-0-0-8825){ref-type="fig"} and [6](#f6-etm-0-0-8825){ref-type="fig"}).

Discussion
==========

KOA is a common chronic joint disease in middle-aged and elderly people, and its incidence and disability rate in the world are extremely high, which poses a serious threat to the health of middle-aged and elderly patients ([@b26-etm-0-0-8825]). At present, magnetic resonance imaging (MRI) has been used to evaluate the degree of cartilage injury in early KOA. Although the specificity is high, the cost is high, and the sensitivity needs to be improved ([@b27-etm-0-0-8825]). Therefore, it is important to explore biomarkers with high specificity and sensitivity for the early diagnosis of KOA.

Increasing number of studies have shown that TLR and IRF play a potential clinical role in the key regulation of KOA cartilage cells and inflammatory factors, although the initiation and progression of KOA have not yet been clarified ([@b28-etm-0-0-8825]). There have been many studies on cartilage cells and inflammatory factors of KOA in TLR-4 and IRF-4. In the study of Liang *et al* ([@b29-etm-0-0-8825]), TLR-4 is highly expressed in type 2 diabetes-related KOA chondrocytes and promotes catabolic and inflammatory processes. The regulatory mechanism may be related to the activation of the nuclear factor κB (NF-κB) pathway by TLR-4 under the stimulation of hyperglycemia. In the study of Jin *et al* ([@b30-etm-0-0-8825]), isofraxidin in KOA competitive inhibition of TLR-4/ bone marrow differentiation protein-2 (MD-2) complex formation, inhibit TLR-4/NF-κB signal cascade, and reduce the level of serum inflammatory cytokines in mouse KOA model. IRF4 is based on ROR gamma t, Th17 as a bridge to establish an indirect relationship with KOA pro-inflammatory factor IL-17. Mudter *et al* ([@b31-etm-0-0-8825]) found that IRF4 can directly bind to IL-17 promoter and induce IL-17 gene expression, resulting in KOA pro-inflammatory factor IL-17([@b32-etm-0-0-8825]). The mechanism of TLR-5 in KOA is mainly mediated by signals related to inflammatory reaction. Lim *et al* ([@b33-etm-0-0-8825]) found that TLR-2 ligand FSL-1 and TLR-5 ligand flagellin mediated inflammatory response through MyD88/TRAF 6/NF-κB-dependent signal. We speculate that TLR-5 may be an important cytokine in osteoarthritis. TLR-5 and NK-κB signaling pathway are related to KOA, and the damage of articular cartilage is related to the high expression of TLR-5. However, in the past, most of the TLR and IRF were concentrated in the mechanism of KOA ([@b34-etm-0-0-8825]). The diagnostic value of the combined detection of TLR-4, TLR-5 and IRF4 in KOA remains to be confirmed.

In this study, the relative expression of serum TLR-4, TLR-5 and IRF4 in the study group were significantly higher than those in the control group, and the sensitivity and specificity of the three methods in the diagnosis of KOA were 94.12 and 97.96%, respectively. This indicates that TLR-4, TLR-5 and IRF4 may be involved in the occurrence and progression of KOA, and the combined detection of KOA has a good predictive value for the early diagnosis of KOA. In the study of Miller *et al* ([@b35-etm-0-0-8825]) on the regulation of TLR on KOA, TLR is not only involved in promoting the pathological changes of KOA joint tissue, but also mediates the pain mechanism of KOA through its signaling pathway. In the study of the relationship between high-level TLR-4 and articular cartilage destruction in patients with KOA by Ospelt *et al* ([@b36-etm-0-0-8825]), the high expression of TLR-4 in serum of patients with early KOA accelerated the process of articular cartilage damage and increased the risk of disability. In the study of Lee *et al* ([@b37-etm-0-0-8825]) on the treatment of KOA involving IRF4, IRF4 was involved in a new path of pathological development of inflammatory KOA; the therapeutic inhibition of IRF4 is beneficial to alleviate pain and disease progression in KOA patients. We speculate that TLR-4, TLR-5 and IRF4 may play a role in the development of KOA. Further studies have shown that TLR-4 and TLR-5 combined with IRF4 have some predictive value for the severity of patients with KOA. Therefore, TLR-4, TLR-5 and IRF4 may play a key role in the diagnosis and severity assessment of patients with KOA. In the study on the activity of KOA diseases by Ding *et al* ([@b38-etm-0-0-8825]), IL-37 was positively correlated with the activity of KOA, and inhibited the production of pro-inflammatory cytokines such as IL-1β, IL-6 and TNF-α in synovial cells, suggesting that IL-37 may also be a potential therapeutic target for KOA inflammation.

Inflammatory mediators IL-1β, IL-6, MMP-1 and TNF-α are very important in the occurrence, progression and pathological changes of KOA. IL-1β can trigger the increase of IL-6, MMP-1, while IL-6 is related to cartilage synthesis and catabolism; MMP-1 is related to apoptosis of cartilage cells, and TNF-α is related to the function or molecular dysfunction of articular cartilage cells ([@b39-etm-0-0-8825]). Zheng *et al* ([@b42-etm-0-0-8825]) reported that purple rivet can inhibit IL-1β induced inflammatory response in human osteoarthritis cartilage cells and slow the development of osteoarthritis in mice. Zeng *et al* ([@b43-etm-0-0-8825]) found that the levels of MMP-1, MMP-2 and MMP-9 protein in patients with KOA were higher than those in the control group. Matrix metalloproteinases aggravated the inflammatory reaction and degradation of cartilage matrix by enhancing apoptosis of cartilage cells and inhibiting the metabolism of cartilage matrix. In the report of Stannus *et al* ([@b44-etm-0-0-8825]), TNF-α and IL-6 changes are associated with increased loss of medial and lateral tibial cartilage volume, and serum IL-6 and TNF-α levels are associated with knee cartilage loss in the elderly, suggesting that low levels of inflammation play a role in the pathogenesis of KOA. In this study, the levels of serum IL-1β and IL-6, MMP-1, TNF-α in the study group were higher than those in the control group, and TLR-4, TLR-5 and IRF4 were positively correlated with IL-1β, IL-6, MMP-1 and TNF-α, respectively. Therefore, TLR-4, TLR-5 and IRF4 may be related to cartilage apoptosis and inflammatory factor markers in KOA, but the specific mechanism needs to be further explored.

This study confirmed the role of combined detection of TLR-4, TLR-5 and IRF4 in the early diagnosis and prognosis evaluation of KOA.

In conclusion, the combined detection of TLR-4, TLR-5 and IRF4 can diagnose early KOA and evaluate the poor prognosis of patients with KOA, which is related to IL-1β, IL-6, MMP-1 and TNF-α.
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![Serum TLR-4, TLR-5 and IRF4 levels in patients with different K-L grades. (A) The level of serum TLR-4 of the patients increased with the increase of K-L grades. (B) The level of serum TLR-5 of the patients increased with the increase of K-L grades. (C) The level of serum IRF4 of the patients increased with the increase of K-L grades. ^\*^P\<0.05, ^\*\*^P\<0.01, ^\*\*\*^P\<0.001. TLR-4, toll-like receptor-4; TLR-5, toll-like receptor-5; IRF4, interferon regulatory factor 4.](etm-20-02-1291-g01){#f2-etm-0-0-8825}

![There is a positive correlation between serum TLR-4 (A), TLR-5 (B), IRF4 (C) and K-L grades. There is a positive correlation between serum TLR-4 (A), TLR-5 (B), IRF4 (C) and K-L grades (r=0.734, P\<0.001; r=0.701, P\<0.001; r=0.784, P\<0.001). TLR-4, toll-like receptor-4; TLR-5, toll-like receptor-5; IRF4, interferon regulatory factor 4.](etm-20-02-1291-g02){#f3-etm-0-0-8825}

![ROC curves of KOA diagnosed by serum TLR-4, TLR-5 and IRF-4. The AUC of serum TLR-4 in the diagnosis of KOA was 0.865, the cut-off value was 5.38 ng/l, the sensitivity was 76.47%, and the specificity was 93.88%. The AUC of serum TLR-5 in the diagnosis of KOA was 0.843, the cut-off value was 4.05 ng/l, the sensitivity was 73.29%, and the specificity was 87.76%. The AUC of serum IRF4 in the diagnosis of KOA was 0.861, the cut-off value was 7.68 ng/l, the sensitivity was 72.06%, and the specificity was 95.92%. The AUC of serum TLR-4, TLR-5 and IRF4 in the combined diagnosis of KOA was 0.971, the cut-off value was 0.63, the sensitivity was 94.12%, and the specificity was 97.96%. ROC, receiver operating characteristic; KOA, knee osteoarthritis; TLR-4, toll-like receptor-4; TLR-5, toll-like receptor-5; IRF4, interferon regulatory factor 4.](etm-20-02-1291-g03){#f4-etm-0-0-8825}

![Comparison of serum IL-1β, IL-6, MMP-1 and TNF-α levels between control group and study group. (A) The level of serum IL-1β in the study group was significantly higher than that in the control group (P\<0.001). (B) The level of serum IL-6 in the study group was significantly higher than that in the control group (P\<0.001). (C) The level of serum MMP-1 in the study group was significantly higher than that in the control group (P\<0.001). (D) The level of serum TNF-α in the study group was significantly higher than that in the control group (P\<0.001). ^\*\*\*^P\<0.001. IL-1β, interleukin 1β; IL-6, interleukin-6; MMP-1, matrix metalloproteinase-1; TNF-α, tumor necrosis factor-α.](etm-20-02-1291-g04){#f5-etm-0-0-8825}

![Correlation of serum TLR-4, TLR-5 and IRF4 expression in the study group with IL-1β, IL-6, MMP-1 and TNF-α levels. (A-D) A positive correlation between serum TLR-4 and IL-1β and IL-6, MMP-1, TNF-α, respectively (r=0.748, P\<0.001; r=0.720, P\<0.001; r=0.735, P\<0.001; r=0.742, P\<0.001). (E-H) The relative expression of TLR-5 in serum was positively correlated with the levels of IL-1β and IL-6, MMP-1, TNF-α, respectively (r=0.807, P\<0.001; r=0.799, P\<0.001; r=0.811, P\<0.001; r=0.822, P\<0.001). (I-L) Relative expression of IRF4 in serum was positively correlated with the levels of IL-1β and IL-6, MMP-1, TNF-α, respectively (r=0.758, P\<0.001; r=0.752, P\<0.001; r=0.779, P\<0.001; r=0.765, P\<0.001). TLR-4, toll-like receptor-4 (TLR-4); TLR-5, toll-like receptor-5; IRF4, interferon regulatory factor 4; IL-1β, interleukin 1β; IL-6, interleukin-6; MMP-1, matrix metalloproteinase-1; TNF-α, tumor necrosis factor-α.](etm-20-02-1291-g05){#f6-etm-0-0-8825}

###### 

Comparison of general information between the two groups \[n (%)\], mean ± SD.

  Group                 Control group   Study group   t/χ^2^ value   P-value
  --------------------- --------------- ------------- -------------- ---------
  Sex                                                 0.099          0.754
       Male             15 (30.61)      19 (27.94)                    
       Female           34 (69.39)      49 (72.06)                    
  Age (years)           55.15±15.69     54.38±13.89   0.280          0.780
  BMI (kg/m^2^)         22.04±1.95      22.56±2.19    1.326          0.188
  Smoking                                             0.696          0.404
       Yes              31 (63.27)      48 (70.59)                    
       No               18 (36.73)      20 (29.41)                    
  Resident place                                      0.461          0.497
       City             24 (48.98)      29 (42.65)                    
       Countryside      25 (51.02)      39 (57.35)                    
  Degree of education                                 2.535          0.111
       ≥High school     23 (46.94)      42 (61.76)                    
       \<High school    26 (53.06)      26 (38.24)                    
  Eating habits                                       2.195          0.139
       Light            34 (69.39)      38 (55.88)                    
       Spicy            15 (30.61)      30 (44.12)                    
  Alcohol consumption                                 0.451          0.502
       Yes              15 (30.61)      17 (25.00)                    
       No               34 (69.39)      51 (75.00)                    
  Marital status                                      1.293          0.524
       Married          44 (88.75)      56 (80.00)                    
       Unmarried        4 (8.75)        10 (15.00)                    
  Bereft of spouse      1 (2.50)        2 (5.00)                      

SD, standard deviation; BMI, body mass index.

###### 

Diagnostic efficacy of serum TLR-4, TLR-5 and IRF4 levels in KOA.

  Group              AUC     95% CI        Standard error   Cut-off value   Sensitivity (%)   Specificity (%)
  ------------------ ------- ------------- ---------------- --------------- ----------------- -----------------
  TLR-4              0.865   0.796-0.934   0.035            5.38 ng/l       76.47             93.88
  TLR-5              0.843   0.801-0.929   0.032            4.05 ng/l       73.29             87.76
  IRF4               0.861   0.792-0.930   0.035            7.68 ng/l       72.06             95.92
  TLR-4+TLR-5+IRF4   0.971   0.959-1.004   0.012            0.63            94.12             97.96

KOA, knee osteoarthritis; TLR-4, toll-like receptor-4; TLR-5, toll-like receptor-5; IRF4, interferon regulatory factor 4.
